Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced financial results for its fourth quarter and full year...

Related Keywords

Minnesota ,United States ,Canada ,Vijay Gullapalli ,Kimberly Minarovich Cameron Willis ,Gerry Nuovo ,Seth Dobrin ,Dan Voytas ,Michaela Carr ,Calyxt Inc ,Technology Platform ,Ibm ,Nasdaq ,Calyxt Business Development Contact ,Payroll Protection Program ,Company Annual Report On Form ,Company As Vice ,Company Paycheck Protection Program ,Technology Licensing Leader ,Innovation At Darling Ingredients Inc ,Toll International ,International Replay Number ,Company Biofactory ,Company As Senior Vice ,Business Development ,Chief Executive Officer ,Scientific Advisory Board ,Production System ,Vice President ,Darling Ingredients ,Senior Vice President ,Data Science ,Pete Ball ,Global Chief Artificial Intelligence ,Three Months Ended December ,Fiscal Year ,Paycheck Protection Program ,Bill Koschak ,Chief Financial ,Full Year ,Chief Financial Officer ,Free Replay Number ,Replay Number ,Plant Cell Matrix ,Media Contact ,Investor Relations Contact ,Cameron Willis ,Business Development Contact ,Payroll Protection ,Securities Litigation Reform Act ,Annual Report ,Except Par Value ,Share Amounts ,Thousands Except Shares ,Per Share Amounts ,Ended December ,Calyxt ,Nc ,